126 related articles for article (PubMed ID: 35713165)
1. In vitro susceptibility of canine corneal bacterial pathogens to three cross-linking protocols.
Large TP; Mack S; Villiers E; Oliver J
Vet Ophthalmol; 2023 Apr; 26 Suppl 1():134-142. PubMed ID: 35713165
[TBL] [Abstract][Full Text] [Related]
2. Antimicrobial efficacy of riboflavin/UVA combination (365 nm) in vitro for bacterial and fungal isolates: a potential new treatment for infectious keratitis.
Martins SA; Combs JC; Noguera G; Camacho W; Wittmann P; Walther R; Cano M; Dick J; Behrens A
Invest Ophthalmol Vis Sci; 2008 Aug; 49(8):3402-8. PubMed ID: 18408193
[TBL] [Abstract][Full Text] [Related]
3. An investigation into corneal enzymatic resistance following epithelium-off and epithelium-on corneal cross-linking protocols.
Aldahlawi NH; Hayes S; O'Brart DPS; O'Brart ND; Meek KM
Exp Eye Res; 2016 Dec; 153():141-151. PubMed ID: 27765574
[TBL] [Abstract][Full Text] [Related]
4. Enzymatic Resistance of Corneas Crosslinked Using Riboflavin in Conjunction With Low Energy, High Energy, and Pulsed UVA Irradiation Modes.
Aldahlawi NH; Hayes S; O'Brart DP; Akhbanbetova A; Littlechild SL; Meek KM
Invest Ophthalmol Vis Sci; 2016 Apr; 57(4):1547-52. PubMed ID: 27046119
[TBL] [Abstract][Full Text] [Related]
5. Thermomechanical behavior of collagen-cross-linked porcine cornea.
Spoerl E; Wollensak G; Dittert DD; Seiler T
Ophthalmologica; 2004; 218(2):136-40. PubMed ID: 15004504
[TBL] [Abstract][Full Text] [Related]
6. First proposed efficacy study of high versus standard irradiance and fractionated riboflavin/ultraviolet a cross-linking with equivalent energy exposure.
Krueger RR; Herekar S; Spoerl E
Eye Contact Lens; 2014 Nov; 40(6):353-7. PubMed ID: 25365552
[TBL] [Abstract][Full Text] [Related]
7. The bactericidal effect of two photoactivated chromophore for keratitis-corneal crosslinking protocols (standard vs. accelerated) on bacterial isolates associated with infectious keratitis in companion animals.
Suter A; Schmitt S; Hübschke E; Kowalska M; Hartnack S; Pot S
BMC Vet Res; 2022 Aug; 18(1):317. PubMed ID: 35978428
[TBL] [Abstract][Full Text] [Related]
8. Keratocyte apoptosis after corneal collagen cross-linking using riboflavin/UVA treatment.
Wollensak G; Spoerl E; Wilsch M; Seiler T
Cornea; 2004 Jan; 23(1):43-9. PubMed ID: 14701957
[TBL] [Abstract][Full Text] [Related]
9. Collagen fiber diameter in the rabbit cornea after collagen crosslinking by riboflavin/UVA.
Wollensak G; Wilsch M; Spoerl E; Seiler T
Cornea; 2004 Jul; 23(5):503-7. PubMed ID: 15220736
[TBL] [Abstract][Full Text] [Related]
10. Wound healing in the rabbit cornea after corneal collagen cross-linking with riboflavin and UVA.
Wollensak G; Iomdina E; Dittert DD; Herbst H
Cornea; 2007 Jun; 26(5):600-5. PubMed ID: 17525659
[TBL] [Abstract][Full Text] [Related]
11. Corneal stromal elasticity and viscoelasticity assessed by atomic force microscopy after different cross linking protocols.
Dias J; Diakonis VF; Lorenzo M; Gonzalez F; Porras K; Douglas S; Avila M; Yoo SH; Ziebarth NM
Exp Eye Res; 2015 Sep; 138():1-5. PubMed ID: 26093276
[TBL] [Abstract][Full Text] [Related]
12. Noninvasive real-time assessment of riboflavin consumption in standard and accelerated corneal crosslinking.
Lombardo M; Lombardo G
J Cataract Refract Surg; 2019 Jan; 45(1):80-86. PubMed ID: 30360937
[TBL] [Abstract][Full Text] [Related]
13. Conservative treatment of keratoconus by riboflavin-uva-induced cross-linking of corneal collagen: qualitative investigation.
Mazzotta C; Traversi C; Baiocchi S; Sergio P; Caporossi T; Caporossi A
Eur J Ophthalmol; 2006; 16(4):530-5. PubMed ID: 16952090
[TBL] [Abstract][Full Text] [Related]
14. Biomechanical property analysis after corneal collagen cross-linking in relation to ultraviolet A irradiation time.
Lanchares E; del Buey MA; Cristóbal JA; Lavilla L; Calvo B
Graefes Arch Clin Exp Ophthalmol; 2011 Aug; 249(8):1223-7. PubMed ID: 21494876
[TBL] [Abstract][Full Text] [Related]
15. Antimicrobial efficacy of corneal cross-linking in vitro and in vivo for Fusarium solani: a potential new treatment for fungal keratitis.
Zhu Z; Zhang H; Yue J; Liu S; Li Z; Wang L
BMC Ophthalmol; 2018 Mar; 18(1):65. PubMed ID: 29499665
[TBL] [Abstract][Full Text] [Related]
16. Comparative study of riboflavin-UVA cross-linking and "flash-linking" using surface wave elastometry.
Rocha KM; Ramos-Esteban JC; Qian Y; Herekar S; Krueger RR
J Refract Surg; 2008 Sep; 24(7):S748-51. PubMed ID: 18811123
[TBL] [Abstract][Full Text] [Related]
17. The effect of riboflavin/UVA collagen cross-linking therapy on the structure and hydrodynamic behaviour of the ungulate and rabbit corneal stroma.
Hayes S; Kamma-Lorger CS; Boote C; Young RD; Quantock AJ; Rost A; Khatib Y; Harris J; Yagi N; Terrill N; Meek KM
PLoS One; 2013; 8(1):e52860. PubMed ID: 23349690
[TBL] [Abstract][Full Text] [Related]
18. Stress-strain measurements of human and porcine corneas after riboflavin-ultraviolet-A-induced cross-linking.
Wollensak G; Spoerl E; Seiler T
J Cataract Refract Surg; 2003 Sep; 29(9):1780-5. PubMed ID: 14522301
[TBL] [Abstract][Full Text] [Related]
19. Depth- and direction-dependent changes in solute transport following cross-linking with riboflavin and UVA light in ex vivo porcine cornea.
Hepfer RG; Chen P; Shi C; Rocha KM; Waring GO; Slate EH; Yao H
Exp Eye Res; 2021 Apr; 205():108498. PubMed ID: 33600810
[TBL] [Abstract][Full Text] [Related]
20. Biomechanical efficacy of corneal cross-linking using hypoosmolar riboflavin solution.
Wollensak G; Spörl E
Eur J Ophthalmol; 2019 Sep; 29(5):474-481. PubMed ID: 30255714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
